Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

1.3K
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
1.3K
Hazard Ratio01:12

Hazard Ratio

756
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
756
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

712
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
712
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

357
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
357
Causality in Epidemiology01:21

Causality in Epidemiology

2.2K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Analysis Comparing Persistence and Adherence of Delayed-Release/Extended-Release Methylphenidate with Stimulant Medications Among Patients with Attention-Deficit/Hyperactivity Disorder in the United States.

Clinical therapeutics·2026
Same author

Hospital-Treated Severe Hypoglycemia in Type 1 Diabetes in the US: A Retrospective Claims-Based Study of Diabetes-Related Complications and Direct Medical Costs.

Advances in therapy·2026
Same author

Working With Patients Living With Dementia, Delirium and Behaviours of Concern: An Exploration into the Impact on Allied Health Staff Wellbeing.

Dementia (London, England)·2026
Same author

Corrigendum to "Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States" [Respir. Med. 248 (2025) 108337].

Respiratory medicine·2025
Same author

Real-World Impact of Treatment With Liposomal Bupivacaine on Health Care Resource Utilization, Opioid Consumption, and Cost Among Patients Undergoing Total Knee Arthroplasty in Ambulatory Surgical Settings in the United States.

The Journal of arthroplasty·2025
Same author

Disease burden and health-related outcomes of patients discharged from hospital following a COPD exacerbation in the United States.

Respiratory medicine·2025

Related Experiment Video

Updated: May 4, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Probabilistic data linkage: a case study of comparative effectiveness in COPD.

Christopher M Blanchette1, Mitch Dekoven2, Ajita P De2

  • 1University of North Carolina, Charlotte, NC, USA; ; Otsuka America Pharmaceutical Inc., Princeton, NJ, USA;

Drugs in Context
|January 17, 2014
PubMed
Summary
This summary is machine-generated.

Probabilistic data linkage successfully integrated two commercial claims databases for comparative effectiveness research. This method confirmed similar COPD exacerbation outcomes between linked patient cohorts, validating its utility.

Keywords:
COPDambulatory carecomparative effectiveness researchdata linkagemedical record linkageoutcomes researchprescription drugstreatment effectiveness

Related Experiment Videos

Last Updated: May 4, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.3K

Area of Science:

  • Health Services Research
  • Data Science
  • Epidemiology

Background:

  • Comparative effectiveness research (CER) requires advanced methods to overcome limitations in existing data sources.
  • Probabilistic data linkage (PDL) is presented as a novel technique to address these data integration challenges.
  • Utilizing PDL enhances the ability to conduct robust CER using administrative claims data.

Purpose of the Study:

  • To evaluate the effectiveness of probabilistic data linkage in integrating disparate healthcare databases.
  • To assess the risk of COPD-related exacerbations in patients treated with two different therapies.
  • To determine if linked patient cohorts with similar baseline characteristics exhibit comparable outcomes.

Main Methods:

  • A historical retrospective cohort study design was employed.
  • Patients aged 40+ with COPD (ICD-9-CM codes 491.xx, 492.xx, 496) and 3+ years enrollment were selected from two US commercial claims databases.
  • Probabilistic data linkage was used to match patients across databases, with COPD exacerbations as the primary outcome measure within 12 months post-index.

Main Results:

  • The study found comparable rates of COPD exacerbations (39.3-47.1%) and hospitalizations between the two linked databases.
  • Adjusted logistic regression models showed similar odds ratios (0.72-0.74) for exacerbations, indicating consistent treatment effects.
  • Imputed outcomes in Database A further supported the reliability of the linkage and results.

Conclusions:

  • Probabilistic linkage is a viable method for integrating patient data from multiple administrative claims databases.
  • Linked cohorts with similar pre-index characteristics demonstrate comparable post-index outcomes, supporting the validity of PDL in CER.
  • This technique enhances the potential for large-scale comparative effectiveness studies using real-world data.